NLRP3 and Parkinson disease: Serum levels of SIRT1, Nrf2, and NLRP3 independently predict patient-reported outcomes and demonstrate strong discriminative ability for distinguishing PD from healthy controls, underscoring their potential as minimally invasive biomarkers for diagnosis, disease monitoring, and therapeutic targeting.